- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Non-opioid Analgesic Patch market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Non-opioid Analgesic Patch size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Non-opioid Analgesic Patch market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Non-opioid Analgesic Patch market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Capsaicin Patches
Ketoprofen Patches
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Market segment by players, this report covers
GlaxoSmithKline Plc
Pfizer, Inc.
Teikoku Seiyaku Co., Ltd.
Mylan N.V.
Hisamitsu Pharmaceutical Co.,Inc
Acorda Therapeutics, Inc
Endo International plc
Allergan
Teh Seng Pharmaceutical Mfg
IBSA Institut Biochimque SA
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Non-opioid Analgesic Patch product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Non-opioid Analgesic Patch, with revenue, gross margin and global market share of Non-opioid Analgesic Patch from 2019 to 2021.
Chapter 3, the Non-opioid Analgesic Patch competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Non-opioid Analgesic Patch market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Non-opioid Analgesic Patch research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Non-opioid Analgesic Patch
1.2 Classification of Non-opioid Analgesic Patch by Type
1.2.1 Overview: Global Non-opioid Analgesic Patch Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Non-opioid Analgesic Patch Revenue Market Share by Type in 2020
1.2.3 Lidocaine Patches
1.2.4 Diclofenac Patches
1.2.5 Methyl Salicylate Patches
1.2.6 Capsaicin Patches
1.2.7 Ketoprofen Patches
1.2.8 Others
1.3 Global Non-opioid Analgesic Patch Market by Application
1.3.1 Overview: Global Non-opioid Analgesic Patch Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Global Non-opioid Analgesic Patch Market Size & Forecast
1.5 Global Non-opioid Analgesic Patch Market Size and Forecast by Region
1.5.1 Global Non-opioid Analgesic Patch Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Non-opioid Analgesic Patch Market Size by Region, (2016-2021)
1.5.3 North America Non-opioid Analgesic Patch Market Size and Prospect (2016-2026)
1.5.4 Europe Non-opioid Analgesic Patch Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Non-opioid Analgesic Patch Market Size and Prospect (2016-2026)
1.5.6 South America Non-opioid Analgesic Patch Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Non-opioid Analgesic Patch Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-opioid Analgesic Patch Market Drivers
1.6.2 Non-opioid Analgesic Patch Market Restraints
1.6.3 Non-opioid Analgesic Patch Trends Analysis
2 Company Profiles
2.1 GlaxoSmithKline Plc
2.1.1 GlaxoSmithKline Plc Details
2.1.2 GlaxoSmithKline Plc Major Business
2.1.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Product and Solutions
2.1.4 GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GlaxoSmithKline Plc Recent Developments and Future Plans
2.2 Pfizer, Inc.
2.2.1 Pfizer, Inc. Details
2.2.2 Pfizer, Inc. Major Business
2.2.3 Pfizer, Inc. Non-opioid Analgesic Patch Product and Solutions
2.2.4 Pfizer, Inc. Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer, Inc. Recent Developments and Future Plans
2.3 Teikoku Seiyaku Co., Ltd.
2.3.1 Teikoku Seiyaku Co., Ltd. Details
2.3.2 Teikoku Seiyaku Co., Ltd. Major Business
2.3.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product and Solutions
2.3.4 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Teikoku Seiyaku Co., Ltd. Recent Developments and Future Plans
2.4 Mylan N.V.
2.4.1 Mylan N.V. Details
2.4.2 Mylan N.V. Major Business
2.4.3 Mylan N.V. Non-opioid Analgesic Patch Product and Solutions
2.4.4 Mylan N.V. Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Mylan N.V. Recent Developments and Future Plans
2.5 Hisamitsu Pharmaceutical Co.,Inc
2.5.1 Hisamitsu Pharmaceutical Co.,Inc Details
2.5.2 Hisamitsu Pharmaceutical Co.,Inc Major Business
2.5.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product and Solutions
2.5.4 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Hisamitsu Pharmaceutical Co.,Inc Recent Developments and Future Plans
2.6 Acorda Therapeutics, Inc
2.6.1 Acorda Therapeutics, Inc Details
2.6.2 Acorda Therapeutics, Inc Major Business
2.6.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product and Solutions
2.6.4 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Acorda Therapeutics, Inc Recent Developments and Future Plans
2.7 Endo International plc
2.7.1 Endo International plc Details
2.7.2 Endo International plc Major Business
2.7.3 Endo International plc Non-opioid Analgesic Patch Product and Solutions
2.7.4 Endo International plc Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Endo International plc Recent Developments and Future Plans
2.8 Allergan
2.8.1 Allergan Details
2.8.2 Allergan Major Business
2.8.3 Allergan Non-opioid Analgesic Patch Product and Solutions
2.8.4 Allergan Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Allergan Recent Developments and Future Plans
2.9 Teh Seng Pharmaceutical Mfg
2.9.1 Teh Seng Pharmaceutical Mfg Details
2.9.2 Teh Seng Pharmaceutical Mfg Major Business
2.9.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product and Solutions
2.9.4 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Teh Seng Pharmaceutical Mfg Recent Developments and Future Plans
2.10 IBSA Institut Biochimque SA
2.10.1 IBSA Institut Biochimque SA Details
2.10.2 IBSA Institut Biochimque SA Major Business
2.10.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product and Solutions
2.10.4 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 IBSA Institut Biochimque SA Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Non-opioid Analgesic Patch Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Non-opioid Analgesic Patch Players Market Share
3.2.2 Top 10 Non-opioid Analgesic Patch Players Market Share
3.2.3 Market Competition Trend
3.3 Non-opioid Analgesic Patch Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Non-opioid Analgesic Patch Revenue and Market Share by Type (2016-2021)
4.2 Global Non-opioid Analgesic Patch Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Non-opioid Analgesic Patch Revenue Market Share by Application (2016-2021)
5.2 Non-opioid Analgesic Patch Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Non-opioid Analgesic Patch Revenue by Type (2016-2026)
6.2 North America Non-opioid Analgesic Patch Revenue by Application (2016-2026)
6.3 North America Non-opioid Analgesic Patch Market Size by Country
6.3.1 North America Non-opioid Analgesic Patch Revenue by Country (2016-2026)
6.3.2 United States Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
6.3.3 Canada Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
6.3.4 Mexico Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Non-opioid Analgesic Patch Revenue by Type (2016-2026)
7.2 Europe Non-opioid Analgesic Patch Revenue by Application (2016-2026)
7.3 Europe Non-opioid Analgesic Patch Market Size by Country
7.3.1 Europe Non-opioid Analgesic Patch Revenue by Country (2016-2026)
7.3.2 Germany Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
7.3.3 France Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
7.3.5 Russia Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
7.3.6 Italy Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Non-opioid Analgesic Patch Revenue by Type (2016-2026)
8.2 Asia-Pacific Non-opioid Analgesic Patch Revenue by Application (2016-2026)
8.3 Asia-Pacific Non-opioid Analgesic Patch Market Size by Region
8.3.1 Asia-Pacific Non-opioid Analgesic Patch Revenue by Region (2016-2026)
8.3.2 China Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
8.3.3 Japan Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
8.3.4 South Korea Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
8.3.5 India Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
8.3.7 Australia Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Non-opioid Analgesic Patch Revenue by Type (2016-2026)
9.2 South America Non-opioid Analgesic Patch Revenue by Application (2016-2026)
9.3 South America Non-opioid Analgesic Patch Market Size by Country
9.3.1 South America Non-opioid Analgesic Patch Revenue by Country (2016-2026)
9.3.2 Brazil Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
9.3.3 Argentina Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Non-opioid Analgesic Patch Revenue by Type (2016-2026)
10.2 Middle East & Africa Non-opioid Analgesic Patch Revenue by Application (2016-2026)
10.3 Middle East & Africa Non-opioid Analgesic Patch Market Size by Country
10.3.1 Middle East & Africa Non-opioid Analgesic Patch Revenue by Country (2016-2026)
10.3.2 Turkey Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
10.3.4 UAE Non-opioid Analgesic Patch Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Non-opioid Analgesic Patch Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Non-opioid Analgesic Patch Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Non-opioid Analgesic Patch Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Non-opioid Analgesic Patch Revenue (USD Million) by Region (2016-2021)
Table 5. Global Non-opioid Analgesic Patch Revenue Market Share by Region (2021-2026)
Table 6. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithKline Plc Major Business
Table 8. GlaxoSmithKline Plc Non-opioid Analgesic Patch Product and Solutions
Table 9. GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer, Inc. Major Business
Table 12. Pfizer, Inc. Non-opioid Analgesic Patch Product and Solutions
Table 13. Pfizer, Inc. Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Teikoku Seiyaku Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 15. Teikoku Seiyaku Co., Ltd. Major Business
Table 16. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product and Solutions
Table 17. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Mylan N.V. Corporate Information, Head Office, and Major Competitors
Table 19. Mylan N.V. Major Business
Table 20. Mylan N.V. Non-opioid Analgesic Patch Product and Solutions
Table 21. Mylan N.V. Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Hisamitsu Pharmaceutical Co.,Inc Corporate Information, Head Office, and Major Competitors
Table 23. Hisamitsu Pharmaceutical Co.,Inc Major Business
Table 24. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product and Solutions
Table 25. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Acorda Therapeutics, Inc Corporate Information, Head Office, and Major Competitors
Table 27. Acorda Therapeutics, Inc Major Business
Table 28. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product and Solutions
Table 29. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Endo International plc Corporate Information, Head Office, and Major Competitors
Table 31. Endo International plc Major Business
Table 32. Endo International plc Non-opioid Analgesic Patch Product and Solutions
Table 33. Endo International plc Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Allergan Corporate Information, Head Office, and Major Competitors
Table 35. Allergan Major Business
Table 36. Allergan Non-opioid Analgesic Patch Product and Solutions
Table 37. Allergan Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Teh Seng Pharmaceutical Mfg Corporate Information, Head Office, and Major Competitors
Table 39. Teh Seng Pharmaceutical Mfg Major Business
Table 40. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product and Solutions
Table 41. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. IBSA Institut Biochimque SA Corporate Information, Head Office, and Major Competitors
Table 43. IBSA Institut Biochimque SA Major Business
Table 44. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product and Solutions
Table 45. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Non-opioid Analgesic Patch Revenue (USD Million) by Players (2019-2021)
Table 47. Global Non-opioid Analgesic Patch Revenue Share by Players (2019-2021)
Table 48. Breakdown of Non-opioid Analgesic Patch by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Non-opioid Analgesic Patch Players Head Office, Products and Services Provided
Table 50. Non-opioid Analgesic Patch Mergers & Acquisitions in the Past Five Years
Table 51. Non-opioid Analgesic Patch New Entrants and Expansion Plans
Table 52. Global Non-opioid Analgesic Patch Revenue (USD Million) by Type (2016-2021)
Table 53. Global Non-opioid Analgesic Patch Revenue Share by Type (2016-2021)
Table 54. Global Non-opioid Analgesic Patch Revenue Forecast by Type (2021-2026)
Table 55. Global Non-opioid Analgesic Patch Revenue by Application (2016-2021)
Table 56. Global Non-opioid Analgesic Patch Revenue Forecast by Application (2021-2026)
Table 57. North America Non-opioid Analgesic Patch Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Non-opioid Analgesic Patch Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Non-opioid Analgesic Patch Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Non-opioid Analgesic Patch Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Non-opioid Analgesic Patch Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Non-opioid Analgesic Patch Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Non-opioid Analgesic Patch Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Non-opioid Analgesic Patch Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Non-opioid Analgesic Patch Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Non-opioid Analgesic Patch Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Non-opioid Analgesic Patch Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Non-opioid Analgesic Patch Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Non-opioid Analgesic Patch Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Non-opioid Analgesic Patch Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Non-opioid Analgesic Patch Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Non-opioid Analgesic Patch Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Non-opioid Analgesic Patch Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Non-opioid Analgesic Patch Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Non-opioid Analgesic Patch Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Non-opioid Analgesic Patch Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Non-opioid Analgesic Patch Picture
Figure 2. Global Non-opioid Analgesic Patch Revenue Market Share by Type in 2020
Figure 3. Lidocaine Patches
Figure 4. Diclofenac Patches
Figure 5. Methyl Salicylate Patches
Figure 6. Capsaicin Patches
Figure 7. Ketoprofen Patches
Figure 8. Others
Figure 9. Non-opioid Analgesic Patch Revenue Market Share by Application in 2020
Figure 10. Hospital Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Independent Pharmacies & Drug Stores Picture
Figure 13. Global Non-opioid Analgesic Patch Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Non-opioid Analgesic Patch Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Non-opioid Analgesic Patch Revenue Market Share by Region (2016-2026)
Figure 16. Global Non-opioid Analgesic Patch Revenue Market Share by Region in 2020
Figure 17. North America Non-opioid Analgesic Patch Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Non-opioid Analgesic Patch Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Non-opioid Analgesic Patch Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Non-opioid Analgesic Patch Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Non-opioid Analgesic Patch Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Non-opioid Analgesic Patch Market Drivers
Figure 23. Non-opioid Analgesic Patch Market Restraints
Figure 24. Non-opioid Analgesic Patch Market Trends
Figure 25. GlaxoSmithKline Plc Recent Developments and Future Plans
Figure 26. Pfizer, Inc. Recent Developments and Future Plans
Figure 27. Teikoku Seiyaku Co., Ltd. Recent Developments and Future Plans
Figure 28. Mylan N.V. Recent Developments and Future Plans
Figure 29. Hisamitsu Pharmaceutical Co.,Inc Recent Developments and Future Plans
Figure 30. Acorda Therapeutics, Inc Recent Developments and Future Plans
Figure 31. Endo International plc Recent Developments and Future Plans
Figure 32. Allergan Recent Developments and Future Plans
Figure 33. Teh Seng Pharmaceutical Mfg Recent Developments and Future Plans
Figure 34. IBSA Institut Biochimque SA Recent Developments and Future Plans
Figure 35. Global Non-opioid Analgesic Patch Revenue Share by Players in 2020
Figure 36. Non-opioid Analgesic Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Non-opioid Analgesic Patch Revenue Market Share in 2020
Figure 38. Global Top 10 Players Non-opioid Analgesic Patch Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Non-opioid Analgesic Patch Revenue Share by Type in 2020
Figure 41. Global Non-opioid Analgesic Patch Market Share Forecast by Type (2021-2026)
Figure 42. Global Non-opioid Analgesic Patch Revenue Share by Application in 2020
Figure 43. Global Non-opioid Analgesic Patch Market Share Forecast by Application (2021-2026)
Figure 44. North America Non-opioid Analgesic Patch Sales Market Share by Type (2016-2026)
Figure 45. North America Non-opioid Analgesic Patch Sales Market Share by Application (2016-2026)
Figure 46. North America Non-opioid Analgesic Patch Revenue Market Share by Country (2016-2026)
Figure 47. United States Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Non-opioid Analgesic Patch Sales Market Share by Type (2016-2026)
Figure 51. Europe Non-opioid Analgesic Patch Sales Market Share by Application (2016-2026)
Figure 52. Europe Non-opioid Analgesic Patch Revenue Market Share by Country (2016-2026)
Figure 53. Germany Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Non-opioid Analgesic Patch Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Non-opioid Analgesic Patch Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Non-opioid Analgesic Patch Revenue Market Share by Region (2016-2026)
Figure 61. China Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Non-opioid Analgesic Patch Sales Market Share by Type (2016-2026)
Figure 68. South America Non-opioid Analgesic Patch Sales Market Share by Application (2016-2026)
Figure 69. South America Non-opioid Analgesic Patch Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Non-opioid Analgesic Patch Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Non-opioid Analgesic Patch Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Non-opioid Analgesic Patch Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Non-opioid Analgesic Patch Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
